

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | keratinocyte proliferation (GO:0043616) | 9.74991203 |
| 2 | interferon-gamma secretion (GO:0072643) | 9.05057034 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 7.97759992 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 7.97759992 |
| 5 | response to interferon-beta (GO:0035456) | 6.41139304 |
| 6 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 6.41048974 |
| 7 | negative regulation of metanephros development (GO:0072217) | 6.32574434 |
| 8 | peptide hormone processing (GO:0016486) | 6.16155642 |
| 9 | negative regulation of execution phase of apoptosis (GO:1900118) | 6.12142220 |
| 10 | L-alpha-amino acid transmembrane transport (GO:1902475) | 5.92859446 |
| 11 | negative regulation of viral entry into host cell (GO:0046597) | 5.71119557 |
| 12 | oligosaccharide catabolic process (GO:0009313) | 5.64151072 |
| 13 | virion attachment to host cell (GO:0019062) | 5.64068781 |
| 14 | adhesion of symbiont to host cell (GO:0044650) | 5.64068781 |
| 15 | cellular response to vitamin D (GO:0071305) | 5.58474649 |
| 16 | nephron tubule formation (GO:0072079) | 5.57195021 |
| 17 | response to protozoan (GO:0001562) | 5.53546044 |
| 18 | endocrine pancreas development (GO:0031018) | 5.52041293 |
| 19 | response to interferon-alpha (GO:0035455) | 5.43745706 |
| 20 | keratinocyte development (GO:0003334) | 5.38534369 |
| 21 | specification of organ identity (GO:0010092) | 5.04628223 |
| 22 | positive regulation of insulin secretion (GO:0032024) | 4.99179685 |
| 23 | type B pancreatic cell development (GO:0003323) | 4.92645626 |
| 24 | glandular epithelial cell differentiation (GO:0002067) | 4.85187231 |
| 25 | glandular epithelial cell development (GO:0002068) | 4.80787312 |
| 26 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.79586100 |
| 27 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.73711130 |
| 28 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 4.66679282 |
| 29 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.58720516 |
| 30 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 4.57925140 |
| 31 | nephron tubule development (GO:0072080) | 4.57819605 |
| 32 | cGMP-mediated signaling (GO:0019934) | 4.56387768 |
| 33 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.50145356 |
| 34 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 4.49562964 |
| 35 | heart morphogenesis (GO:0003007) | 4.46398445 |
| 36 | drinking behavior (GO:0042756) | 4.45886317 |
| 37 | maturation of SSU-rRNA (GO:0030490) | 4.43773466 |
| 38 | adhesion of symbiont to host (GO:0044406) | 4.37291846 |
| 39 | positive regulation of calcium ion import (GO:0090280) | 4.35572655 |
| 40 | negative regulation of JUN kinase activity (GO:0043508) | 4.32435393 |
| 41 | protein retention in ER lumen (GO:0006621) | 4.26821726 |
| 42 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.20214261 |
| 43 | regulation of viral entry into host cell (GO:0046596) | 4.18859561 |
| 44 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.17017205 |
| 45 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 4.15104939 |
| 46 | cornea development in camera-type eye (GO:0061303) | 4.14287681 |
| 47 | toxin metabolic process (GO:0009404) | 4.12247326 |
| 48 | primary alcohol catabolic process (GO:0034310) | 4.11744400 |
| 49 | regulation of myelination (GO:0031641) | 4.11452733 |
| 50 | protein-cofactor linkage (GO:0018065) | 4.11434278 |
| 51 | renal tubule development (GO:0061326) | 4.10046962 |
| 52 | insulin secretion (GO:0030073) | 4.04019530 |
| 53 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 4.03393603 |
| 54 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.99371996 |
| 55 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.96825149 |
| 56 | positive regulation of peptide hormone secretion (GO:0090277) | 3.96039902 |
| 57 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.94367847 |
| 58 | negative regulation of digestive system process (GO:0060457) | 3.93812642 |
| 59 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.93146361 |
| 60 | regulation of uterine smooth muscle contraction (GO:0070472) | 3.92753225 |
| 61 | determination of left/right symmetry (GO:0007368) | 3.88913179 |
| 62 | neuron fate specification (GO:0048665) | 3.87536498 |
| 63 | astrocyte differentiation (GO:0048708) | 3.83639610 |
| 64 | positive regulation of peptide secretion (GO:0002793) | 3.83089306 |
| 65 | regulation of neurological system process (GO:0031644) | 3.82329428 |
| 66 | cellular response to glucagon stimulus (GO:0071377) | 3.81438201 |
| 67 | nephron tubule morphogenesis (GO:0072078) | 3.78743751 |
| 68 | nephron epithelium morphogenesis (GO:0072088) | 3.78743751 |
| 69 | pattern specification involved in kidney development (GO:0061004) | 3.75685881 |
| 70 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.75413101 |
| 71 | positive regulation of vesicle fusion (GO:0031340) | 3.74945147 |
| 72 | aggressive behavior (GO:0002118) | 3.73784547 |
| 73 | regulation of respiratory system process (GO:0044065) | 3.73033387 |
| 74 | regulation of penile erection (GO:0060405) | 3.72340569 |
| 75 | COPII vesicle coating (GO:0048208) | 3.72055420 |
| 76 | detection of calcium ion (GO:0005513) | 3.72048937 |
| 77 | nephron epithelium development (GO:0072009) | 3.70713206 |
| 78 | regulation of insulin secretion (GO:0050796) | 3.68654150 |
| 79 | inositol metabolic process (GO:0006020) | 3.67064833 |
| 80 | auditory receptor cell differentiation (GO:0042491) | 3.63465248 |
| 81 | determination of bilateral symmetry (GO:0009855) | 3.63214511 |
| 82 | specification of symmetry (GO:0009799) | 3.62843179 |
| 83 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.62144688 |
| 84 | epithelial cell fate commitment (GO:0072148) | 3.61894205 |
| 85 | signal peptide processing (GO:0006465) | 3.61495997 |
| 86 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.61100651 |
| 87 | renal system development (GO:0072001) | 3.60729331 |
| 88 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 3.59612727 |
| 89 | sequestering of metal ion (GO:0051238) | 3.58909220 |
| 90 | cellular response to vitamin (GO:0071295) | 3.58219334 |
| 91 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.58172163 |
| 92 | protein maturation by protein folding (GO:0022417) | 3.53336149 |
| 93 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.48991085 |
| 94 | galactose catabolic process (GO:0019388) | 3.47516042 |
| 95 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.45148372 |
| 96 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.40764901 |
| 97 | renal tubule morphogenesis (GO:0061333) | 3.40271905 |
| 98 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.39341949 |
| 99 | negative regulation of viral genome replication (GO:0045071) | 3.38254688 |
| 100 | extracellular fibril organization (GO:0043206) | 3.35193803 |
| 101 | regulation of peptide hormone secretion (GO:0090276) | 3.34288170 |
| 102 | negative regulation of kidney development (GO:0090185) | 3.33928736 |
| 103 | peptide hormone secretion (GO:0030072) | 3.32670401 |
| 104 | activation of MAPKKK activity (GO:0000185) | 3.32535297 |
| 105 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.31022681 |
| 106 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.29868460 |
| 107 | response to xenobiotic stimulus (GO:0009410) | 3.28641409 |
| 108 | ethanol oxidation (GO:0006069) | 3.28160347 |
| 109 | regulation of peptide secretion (GO:0002791) | 3.28116558 |
| 110 | mesonephros development (GO:0001823) | 3.27467642 |
| 111 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.27331551 |
| 112 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.26457491 |
| 113 | vesicle coating (GO:0006901) | 3.25632800 |
| 114 | positive regulation of gluconeogenesis (GO:0045722) | 3.25099279 |
| 115 | metanephric nephron tubule development (GO:0072234) | 3.24807358 |
| 116 | metanephric tubule development (GO:0072170) | 3.24807358 |
| 117 | peptide secretion (GO:0002790) | 3.24344481 |
| 118 | adaptation of signaling pathway (GO:0023058) | 3.22900168 |
| 119 | response to hepatocyte growth factor (GO:0035728) | 3.22811919 |
| 120 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.22811919 |
| 121 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.22149893 |
| 122 | regulation of respiratory gaseous exchange (GO:0043576) | 3.18874447 |
| 123 | positive regulation of nuclease activity (GO:0032075) | 3.18497688 |
| 124 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.18473225 |
| 125 | retina layer formation (GO:0010842) | 3.18287772 |
| 126 | protein autoprocessing (GO:0016540) | 3.18246803 |
| 127 | positive regulation of astrocyte differentiation (GO:0048711) | 3.18025149 |
| 128 | brown fat cell differentiation (GO:0050873) | 3.18012477 |
| 129 | maternal behavior (GO:0042711) | 3.17756440 |
| 130 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.15461784 |
| 131 | inositol phosphate dephosphorylation (GO:0046855) | 3.15461784 |
| 132 | positive regulation of amino acid transport (GO:0051957) | 3.15329911 |
| 133 | angiotensin maturation (GO:0002003) | 3.10270593 |
| 134 | eating behavior (GO:0042755) | 3.06730768 |
| 135 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.04938804 |
| 136 | parental behavior (GO:0060746) | 3.03515255 |
| 137 | photoreceptor cell differentiation (GO:0046530) | 3.03233239 |
| 138 | eye photoreceptor cell differentiation (GO:0001754) | 3.03233239 |
| 139 | positive regulation of odontogenesis (GO:0042482) | 3.02769856 |
| 140 | embryonic heart tube development (GO:0035050) | 3.01606758 |
| 141 | positive regulation of hormone secretion (GO:0046887) | 2.99978758 |
| 142 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.99715969 |
| 143 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.99702694 |
| 144 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.98115625 |
| 145 | regulation of nuclease activity (GO:0032069) | 2.97815583 |
| 146 | suckling behavior (GO:0001967) | 2.97144322 |
| 147 | exocrine pancreas development (GO:0031017) | 2.95537495 |
| 148 | axon regeneration (GO:0031103) | 2.94870252 |
| 149 | spermatid nucleus differentiation (GO:0007289) | 2.94837259 |
| 150 | response to dietary excess (GO:0002021) | 2.94337105 |
| 151 | inositol phosphate catabolic process (GO:0071545) | 2.89746422 |
| 152 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.89599620 |
| 153 | regulation of hormone secretion (GO:0046883) | 2.88814850 |
| 154 | membrane repolarization during action potential (GO:0086011) | 2.87718710 |
| 155 | ribosomal small subunit biogenesis (GO:0042274) | 2.86603110 |
| 156 | macroautophagy (GO:0016236) | 2.84425307 |
| 157 | macrophage chemotaxis (GO:0048246) | 2.82908985 |
| 158 | metanephric nephron epithelium development (GO:0072243) | 2.81264574 |
| 159 | activation of protein kinase A activity (GO:0034199) | 2.80342118 |
| 160 | regulation of pigment cell differentiation (GO:0050932) | 2.80121889 |
| 161 | feeding behavior (GO:0007631) | 2.79137205 |
| 162 | growth hormone secretion (GO:0030252) | 2.78565182 |
| 163 | response to ischemia (GO:0002931) | 2.77946390 |
| 164 | neural crest cell development (GO:0014032) | 2.76669626 |
| 165 | inner ear receptor cell differentiation (GO:0060113) | 2.76608715 |
| 166 | chemosensory behavior (GO:0007635) | 2.76198848 |
| 167 | ER overload response (GO:0006983) | 2.75868187 |
| 168 | viral transcription (GO:0019083) | 2.72904850 |
| 169 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.72377052 |
| 170 | fibril organization (GO:0097435) | 2.72230891 |
| 171 | response to glucagon (GO:0033762) | 2.71866625 |
| 172 | regulation of cell fate specification (GO:0042659) | 2.70237423 |
| 173 | lipopolysaccharide metabolic process (GO:0008653) | 2.69256426 |
| 174 | urogenital system development (GO:0001655) | 2.68924585 |
| 175 | negative regulation of glycogen metabolic process (GO:0070874) | 2.68555692 |
| 176 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.67541384 |
| 177 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.67525684 |
| 178 | regulation of peptide transport (GO:0090087) | 2.67365708 |
| 179 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.66640331 |
| 180 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.66640331 |
| 181 | angiogenesis involved in wound healing (GO:0060055) | 2.66285343 |
| 182 | ear development (GO:0043583) | 2.65630759 |
| 183 | secondary heart field specification (GO:0003139) | 2.65586129 |
| 184 | * regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.65244333 |
| 185 | * regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.65244333 |
| 186 | * endocrine process (GO:0050886) | 2.65244333 |
| 187 | regulation of vesicle fusion (GO:0031338) | 2.63221829 |
| 188 | cellular response to unfolded protein (GO:0034620) | 2.62156564 |
| 189 | hormone secretion (GO:0046879) | 2.61305898 |
| 190 | nitric oxide mediated signal transduction (GO:0007263) | 2.61274929 |
| 191 | peptide transport (GO:0015833) | 2.60925756 |
| 192 | regulation of norepinephrine secretion (GO:0014061) | 2.59505121 |
| 193 | ER-nucleus signaling pathway (GO:0006984) | 2.59497723 |
| 194 | regulation of calcium ion import (GO:0090279) | 2.59365867 |
| 195 | regulation of axon regeneration (GO:0048679) | 11.8857041 |
| 196 | regulation of neuron projection regeneration (GO:0070570) | 11.8857041 |
| 197 | negative regulation of neurological system process (GO:0031645) | 10.7390272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 7.83291016 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 7.83291016 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 7.83291016 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 7.80424658 |
| 5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.40263251 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.75141170 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.64730116 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.59785632 |
| 9 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.45830884 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.45447333 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.32908826 |
| 12 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.29584013 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.21243395 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.13974943 |
| 15 | EGR1_19032775_ChIP-ChIP_M12_Human | 2.13037124 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.12929831 |
| 17 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 2.05248641 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.04214214 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.99239373 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.97504084 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.95495038 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.88115807 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86838226 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.85708247 |
| 25 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.82835099 |
| 26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.81004347 |
| 27 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.80736926 |
| 28 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.80552188 |
| 29 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77087054 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.76484630 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.75443179 |
| 32 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.74538594 |
| 33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.72719605 |
| 34 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.70297502 |
| 35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.69355219 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.67771668 |
| 37 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.65900329 |
| 38 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.65814386 |
| 39 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.64081351 |
| 40 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.63755915 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.62679333 |
| 42 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.59565112 |
| 43 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.59213461 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.58591381 |
| 45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.56591435 |
| 46 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.56412913 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.56310472 |
| 48 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.55842307 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54412976 |
| 50 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.54406626 |
| 51 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.50252678 |
| 52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.49299707 |
| 53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.43523686 |
| 54 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.43279306 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.42978548 |
| 56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42379951 |
| 57 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42115824 |
| 58 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.41079593 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.41072761 |
| 60 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.39693417 |
| 61 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.38208541 |
| 62 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.38208541 |
| 63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.37120564 |
| 64 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.34954848 |
| 65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.33839703 |
| 66 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.32656705 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.32609569 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.30603173 |
| 69 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29692022 |
| 70 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.28539407 |
| 71 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.27883541 |
| 72 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27443047 |
| 73 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.26487800 |
| 74 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.26428879 |
| 75 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25823419 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23638730 |
| 77 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.20777616 |
| 78 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19564900 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19049783 |
| 80 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.17207363 |
| 81 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17124174 |
| 82 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16743426 |
| 83 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.15843183 |
| 84 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.15540936 |
| 85 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.14893501 |
| 86 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13903233 |
| 87 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13352194 |
| 88 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13331770 |
| 89 | AR_19668381_ChIP-Seq_PC3_Human | 1.12362145 |
| 90 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11386182 |
| 91 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10886605 |
| 92 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07911414 |
| 93 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07746956 |
| 94 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06655257 |
| 95 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.05855353 |
| 96 | P300_19829295_ChIP-Seq_ESCs_Human | 1.05841523 |
| 97 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04182595 |
| 98 | * ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04155555 |
| 99 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03807886 |
| 100 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.03556135 |
| 101 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03396307 |
| 102 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.02772101 |
| 103 | AR_20517297_ChIP-Seq_VCAP_Human | 1.02130240 |
| 104 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01931368 |
| 105 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01924405 |
| 106 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01049801 |
| 107 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.00786627 |
| 108 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00567930 |
| 109 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00177392 |
| 110 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99876654 |
| 111 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99423507 |
| 112 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98434023 |
| 113 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98360401 |
| 114 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96520070 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96466489 |
| 116 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.96248847 |
| 117 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.95969574 |
| 118 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95432479 |
| 119 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.95374889 |
| 120 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94636822 |
| 121 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94147791 |
| 122 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.94040380 |
| 123 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94022185 |
| 124 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93662775 |
| 125 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92862130 |
| 126 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.92134248 |
| 127 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.91961158 |
| 128 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91801001 |
| 129 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90474553 |
| 130 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90214478 |
| 131 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89911339 |
| 132 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.89850362 |
| 133 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.89545703 |
| 134 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.89169635 |
| 135 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.89016888 |
| 136 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88872488 |
| 137 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87937997 |
| 138 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.87766901 |
| 139 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.87676762 |
| 140 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.87363701 |
| 141 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87034191 |
| 142 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.86877424 |
| 143 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.86004090 |
| 144 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85922621 |
| 145 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.84463838 |
| 146 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.79945106 |
| 147 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79548468 |
| 148 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79515507 |
| 149 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.79133468 |
| 150 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.79045234 |
| 151 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.77925982 |
| 152 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.77514388 |
| 153 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76100744 |
| 154 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.74554906 |
| 155 | VDR_22108803_ChIP-Seq_LS180_Human | 0.73602679 |
| 156 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73043986 |
| 157 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71984628 |
| 158 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.70746708 |
| 159 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.69754963 |
| 160 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.69267315 |
| 161 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.69142128 |
| 162 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.68399603 |
| 163 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.67526351 |
| 164 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.66993018 |
| 165 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.65793124 |
| 166 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.65727951 |
| 167 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.65093606 |
| 168 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.64154633 |
| 169 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.62899173 |
| 170 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.62636822 |
| 171 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61173710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004133_heterotaxia | 7.87995747 |
| 2 | MP0000013_abnormal_adipose_tissue | 5.99130668 |
| 3 | MP0003183_abnormal_peptide_metabolism | 5.35368784 |
| 4 | MP0003195_calcinosis | 4.72054957 |
| 5 | MP0002653_abnormal_ependyma_morphology | 4.34996919 |
| 6 | MP0005645_abnormal_hypothalamus_physiol | 4.33626580 |
| 7 | MP0000003_abnormal_adipose_tissue | 4.15932707 |
| 8 | MP0005379_endocrine/exocrine_gland_phen | 4.12089486 |
| 9 | MP0002909_abnormal_adrenal_gland | 3.77946434 |
| 10 | MP0009379_abnormal_foot_pigmentation | 3.56805095 |
| 11 | MP0000372_irregular_coat_pigmentation | 3.50412282 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 3.42343171 |
| 13 | MP0010386_abnormal_urinary_bladder | 3.38166427 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 3.35093372 |
| 15 | MP0001944_abnormal_pancreas_morphology | 3.18992777 |
| 16 | MP0004272_abnormal_basement_membrane | 3.13951631 |
| 17 | MP0000566_synostosis | 3.03326959 |
| 18 | MP0002693_abnormal_pancreas_physiology | 3.01587722 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 2.98075737 |
| 20 | MP0003283_abnormal_digestive_organ | 2.70908175 |
| 21 | MP0000678_abnormal_parathyroid_gland | 2.51981688 |
| 22 | MP0002822_catalepsy | 2.36104151 |
| 23 | MP0004043_abnormal_pH_regulation | 2.28639078 |
| 24 | MP0005187_abnormal_penis_morphology | 2.21034984 |
| 25 | MP0005058_abnormal_lysosome_morphology | 2.13906784 |
| 26 | MP0009765_abnormal_xenobiotic_induced | 2.11366998 |
| 27 | MP0009785_altered_susceptibility_to | 2.07882721 |
| 28 | MP0005220_abnormal_exocrine_pancreas | 2.05904071 |
| 29 | MP0002132_abnormal_respiratory_system | 2.01731448 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.99992978 |
| 31 | MP0004270_analgesia | 1.95493274 |
| 32 | MP0003122_maternal_imprinting | 1.92138780 |
| 33 | MP0002078_abnormal_glucose_homeostasis | 1.91796515 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.91486149 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.90163812 |
| 36 | MP0005375_adipose_tissue_phenotype | 1.89422247 |
| 37 | MP0003938_abnormal_ear_development | 1.87267277 |
| 38 | MP0003879_abnormal_hair_cell | 1.86380724 |
| 39 | MP0000681_abnormal_thyroid_gland | 1.79769959 |
| 40 | MP0003943_abnormal_hepatobiliary_system | 1.78982092 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 1.71722576 |
| 42 | MP0003950_abnormal_plasma_membrane | 1.66245498 |
| 43 | MP0001765_abnormal_ion_homeostasis | 1.59479842 |
| 44 | MP0002234_abnormal_pharynx_morphology | 1.56358605 |
| 45 | MP0004510_myositis | 1.55867162 |
| 46 | MP0003868_abnormal_feces_composition | 1.53666033 |
| 47 | MP0006072_abnormal_retinal_apoptosis | 1.53537741 |
| 48 | MP0002638_abnormal_pupillary_reflex | 1.53494083 |
| 49 | MP0006054_spinal_hemorrhage | 1.50962668 |
| 50 | MP0004145_abnormal_muscle_electrophysio | 1.48847297 |
| 51 | MP0003787_abnormal_imprinting | 1.47953756 |
| 52 | MP0002163_abnormal_gland_morphology | 1.46090037 |
| 53 | MP0001756_abnormal_urination | 1.43781570 |
| 54 | MP0003959_abnormal_lean_body | 1.40826041 |
| 55 | MP0000049_abnormal_middle_ear | 1.37222311 |
| 56 | MP0000647_abnormal_sebaceous_gland | 1.36740806 |
| 57 | MP0005365_abnormal_bile_salt | 1.35668744 |
| 58 | MP0000383_abnormal_hair_follicle | 1.32217607 |
| 59 | MP0003186_abnormal_redox_activity | 1.31491487 |
| 60 | MP0002896_abnormal_bone_mineralization | 1.30220359 |
| 61 | MP0005257_abnormal_intraocular_pressure | 1.30158309 |
| 62 | MP0002734_abnormal_mechanical_nocicepti | 1.29263977 |
| 63 | MP0004264_abnormal_extraembryonic_tissu | 1.28026203 |
| 64 | MP0001270_distended_abdomen | 1.23941031 |
| 65 | MP0001188_hyperpigmentation | 1.19497767 |
| 66 | MP0000613_abnormal_salivary_gland | 1.17813221 |
| 67 | MP0000230_abnormal_systemic_arterial | 1.14091599 |
| 68 | MP0009763_increased_sensitivity_to | 1.13995358 |
| 69 | MP0002733_abnormal_thermal_nociception | 1.12930755 |
| 70 | MP0005171_absent_coat_pigmentation | 1.11757251 |
| 71 | MP0002938_white_spotting | 1.08918431 |
| 72 | MP0004381_abnormal_hair_follicle | 1.05954461 |
| 73 | * MP0003953_abnormal_hormone_level | 1.05206981 |
| 74 | MP0004019_abnormal_vitamin_homeostasis | 1.04431389 |
| 75 | MP0001666_abnormal_nutrient_absorption | 1.04295017 |
| 76 | MP0003011_delayed_dark_adaptation | 1.00172421 |
| 77 | MP0002089_abnormal_postnatal_growth/wei | 0.99459195 |
| 78 | MP0000538_abnormal_urinary_bladder | 0.98458189 |
| 79 | MP0002102_abnormal_ear_morphology | 0.96796585 |
| 80 | MP0001986_abnormal_taste_sensitivity | 0.96716785 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 0.96108499 |
| 82 | MP0003045_fibrosis | 0.94933671 |
| 83 | MP0009643_abnormal_urine_homeostasis | 0.94187192 |
| 84 | MP0008961_abnormal_basal_metabolism | 0.94000928 |
| 85 | MP0006292_abnormal_olfactory_placode | 0.93527945 |
| 86 | * MP0002064_seizures | 0.93078198 |
| 87 | MP0005377_hearing/vestibular/ear_phenot | 0.92952823 |
| 88 | MP0003878_abnormal_ear_physiology | 0.92952823 |
| 89 | MP0002095_abnormal_skin_pigmentation | 0.89974272 |
| 90 | MP0002751_abnormal_autonomic_nervous | 0.87831703 |
| 91 | MP0004147_increased_porphyrin_level | 0.87094802 |
| 92 | MP0003136_yellow_coat_color | 0.85990511 |
| 93 | MP0000631_abnormal_neuroendocrine_gland | 0.85318184 |
| 94 | MP0001905_abnormal_dopamine_level | 0.83783542 |
| 95 | MP0005671_abnormal_response_to | 0.83732966 |
| 96 | MP0001970_abnormal_pain_threshold | 0.83587430 |
| 97 | MP0001664_abnormal_digestion | 0.81757542 |
| 98 | MP0005448_abnormal_energy_balance | 0.80330491 |
| 99 | MP0002928_abnormal_bile_duct | 0.80198760 |
| 100 | MP0006276_abnormal_autonomic_nervous | 0.79249036 |
| 101 | MP0003633_abnormal_nervous_system | 0.78150527 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 0.77051013 |
| 103 | MP0003121_genomic_imprinting | 0.75600022 |
| 104 | MP0005253_abnormal_eye_physiology | 0.74426629 |
| 105 | MP0002184_abnormal_innervation | 0.73433663 |
| 106 | MP0005636_abnormal_mineral_homeostasis | 0.73327898 |
| 107 | MP0005334_abnormal_fat_pad | 0.72445853 |
| 108 | MP0005367_renal/urinary_system_phenotyp | 0.72063988 |
| 109 | MP0000516_abnormal_urinary_system | 0.72063988 |
| 110 | MP0000462_abnormal_digestive_system | 0.71957547 |
| 111 | MP0003635_abnormal_synaptic_transmissio | 0.71791664 |
| 112 | MP0002932_abnormal_joint_morphology | 0.71572062 |
| 113 | MP0000534_abnormal_ureter_morphology | 0.70675586 |
| 114 | MP0004808_abnormal_hematopoietic_stem | 0.70316073 |
| 115 | MP0009046_muscle_twitch | 0.69980646 |
| 116 | MP0001853_heart_inflammation | 0.69149407 |
| 117 | MP0002069_abnormal_eating/drinking_beha | 0.68132053 |
| 118 | MP0005408_hypopigmentation | 0.67953688 |
| 119 | MP0000955_abnormal_spinal_cord | 0.66375623 |
| 120 | * MP0002557_abnormal_social/conspecific_i | 0.66089609 |
| 121 | MP0005085_abnormal_gallbladder_physiolo | 0.65873995 |
| 122 | MP0009840_abnormal_foam_cell | 0.65710105 |
| 123 | MP0001502_abnormal_circadian_rhythm | 0.65621172 |
| 124 | MP0005535_abnormal_body_temperature | 0.64779939 |
| 125 | MP0001299_abnormal_eye_distance/ | 0.64702393 |
| 126 | MP0005451_abnormal_body_composition | 0.63201359 |
| 127 | MP0001879_abnormal_lymphatic_vessel | 0.63176249 |
| 128 | MP0005670_abnormal_white_adipose | 0.62978740 |
| 129 | * MP0009745_abnormal_behavioral_response | 0.62962076 |
| 130 | MP0000579_abnormal_nail_morphology | 0.62618035 |
| 131 | MP0005646_abnormal_pituitary_gland | 0.62413037 |
| 132 | MP0005452_abnormal_adipose_tissue | 0.61585165 |
| 133 | MP0001851_eye_inflammation | 0.61295290 |
| 134 | MP0005464_abnormal_platelet_physiology | 0.61136712 |
| 135 | MP0005025_abnormal_response_to | 0.60236868 |
| 136 | MP0003123_paternal_imprinting | 0.59598257 |
| 137 | MP0003252_abnormal_bile_duct | 0.58669386 |
| 138 | MP0002168_other_aberrant_phenotype | 0.57039412 |
| 139 | MP0005409_darkened_coat_color | 0.56705569 |
| 140 | MP0002177_abnormal_outer_ear | 0.56034462 |
| 141 | MP0005551_abnormal_eye_electrophysiolog | 0.55542569 |
| 142 | MP0005023_abnormal_wound_healing | 0.55469909 |
| 143 | * MP0002572_abnormal_emotion/affect_behav | 0.54982649 |
| 144 | MP0001346_abnormal_lacrimal_gland | 0.54970315 |
| 145 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54844505 |
| 146 | MP0003119_abnormal_digestive_system | 0.54551601 |
| 147 | MP0004858_abnormal_nervous_system | 0.54253677 |
| 148 | MP0002876_abnormal_thyroid_physiology | 0.53915479 |
| 149 | MP0001485_abnormal_pinna_reflex | 0.51948252 |
| 150 | MP0008789_abnormal_olfactory_epithelium | 0.51791576 |
| 151 | MP0001661_extended_life_span | 0.51424003 |
| 152 | MP0002272_abnormal_nervous_system | 0.50826648 |
| 153 | MP0004885_abnormal_endolymph | 0.50190989 |
| 154 | MP0003866_abnormal_defecation | 0.49066187 |
| 155 | MP0001919_abnormal_reproductive_system | 0.48856934 |
| 156 | MP0010678_abnormal_skin_adnexa | 0.48784024 |
| 157 | MP0002998_abnormal_bone_remodeling | 0.48486200 |
| 158 | MP0002092_abnormal_eye_morphology | 0.47027600 |
| 159 | MP0004134_abnormal_chest_morphology | 0.45716895 |
| 160 | MP0001963_abnormal_hearing_physiology | 0.45476862 |
| 161 | MP0005195_abnormal_posterior_eye | 0.45183573 |
| 162 | MP0005391_vision/eye_phenotype | 0.45102796 |
| 163 | MP0000026_abnormal_inner_ear | 0.44842225 |
| 164 | MP0008873_increased_physiological_sensi | 0.43799329 |
| 165 | MP0002098_abnormal_vibrissa_morphology | 0.43327258 |
| 166 | MP0000598_abnormal_liver_morphology | 0.42716231 |
| 167 | MP0003724_increased_susceptibility_to | 0.42212634 |
| 168 | MP0009250_abnormal_appendicular_skeleto | 0.42167491 |
| 169 | MP0002108_abnormal_muscle_morphology | 0.40926890 |
| 170 | MP0005076_abnormal_cell_differentiation | 0.40824306 |
| 171 | MP0001614_abnormal_blood_vessel | 0.39819222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 9.45970494 |
| 2 | Abnormality of the lower motor neuron (HP:0002366) | 9.13051537 |
| 3 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.39868600 |
| 4 | Ankle contracture (HP:0006466) | 7.23743128 |
| 5 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 6.06090523 |
| 6 | Hypoglycemic seizures (HP:0002173) | 6.04346768 |
| 7 | Symptomatic seizures (HP:0011145) | 5.96933531 |
| 8 | Impulsivity (HP:0100710) | 5.54997217 |
| 9 | Large for gestational age (HP:0001520) | 5.50855519 |
| 10 | Hyperglycemia (HP:0003074) | 5.22900204 |
| 11 | Thyroid-stimulating hormone excess (HP:0002925) | 5.20209866 |
| 12 | Pancreatic islet-cell hyperplasia (HP:0004510) | 5.16635443 |
| 13 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.97447832 |
| 14 | Ketoacidosis (HP:0001993) | 4.78835101 |
| 15 | Hypoglycemic coma (HP:0001325) | 4.70759936 |
| 16 | Agitation (HP:0000713) | 4.65700629 |
| 17 | 3-Methylglutaconic aciduria (HP:0003535) | 4.53343205 |
| 18 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.51624345 |
| 19 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.51624345 |
| 20 | Concave nail (HP:0001598) | 4.26003721 |
| 21 | Abnormality of the nasal septum (HP:0000419) | 4.16890386 |
| 22 | Prolonged neonatal jaundice (HP:0006579) | 3.98666636 |
| 23 | Progressive visual loss (HP:0000529) | 3.73619831 |
| 24 | Hyperparathyroidism (HP:0000843) | 3.70817584 |
| 25 | Scapular winging (HP:0003691) | 3.70389293 |
| 26 | Stenosis of the external auditory canal (HP:0000402) | 3.62619177 |
| 27 | Craniofacial dystonia (HP:0012179) | 3.46937241 |
| 28 | Retinal atrophy (HP:0001105) | 3.41973009 |
| 29 | Congenital sensorineural hearing impairment (HP:0008527) | 3.40129745 |
| 30 | Nasolacrimal duct obstruction (HP:0000579) | 3.34460626 |
| 31 | Hyperphosphatemia (HP:0002905) | 3.32568173 |
| 32 | Late onset (HP:0003584) | 3.32320459 |
| 33 | Papilledema (HP:0001085) | 3.28398150 |
| 34 | Hypsarrhythmia (HP:0002521) | 3.25682058 |
| 35 | EEG with generalized epileptiform discharges (HP:0011198) | 3.24237998 |
| 36 | Conical tooth (HP:0000698) | 3.23833216 |
| 37 | Epileptiform EEG discharges (HP:0011182) | 3.18980045 |
| 38 | Focal dystonia (HP:0004373) | 3.18407684 |
| 39 | Hoarse voice (HP:0001609) | 3.13697692 |
| 40 | Patchy hypopigmentation of hair (HP:0011365) | 3.09610872 |
| 41 | Hypoplasia of the uterus (HP:0000013) | 3.08111265 |
| 42 | Decreased circulating renin level (HP:0003351) | 3.01203495 |
| 43 | Focal motor seizures (HP:0011153) | 3.00101348 |
| 44 | Increased circulating renin level (HP:0000848) | 2.94951558 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.91315328 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.89962745 |
| 47 | Mucopolysacchariduria (HP:0008155) | 2.89962745 |
| 48 | Unilateral renal agenesis (HP:0000122) | 2.89943256 |
| 49 | Lip pit (HP:0100267) | 2.88153323 |
| 50 | Abolished electroretinogram (ERG) (HP:0000550) | 2.87355007 |
| 51 | Osteomalacia (HP:0002749) | 2.85976015 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.85526757 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.85526757 |
| 54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.85526757 |
| 55 | Blue irides (HP:0000635) | 2.84401581 |
| 56 | Abnormality of the motor neurons (HP:0002450) | 2.84246573 |
| 57 | Abnormal neuron morphology (HP:0012757) | 2.84246573 |
| 58 | Prominent metopic ridge (HP:0005487) | 2.82786714 |
| 59 | Macroorchidism (HP:0000053) | 2.81349342 |
| 60 | Myokymia (HP:0002411) | 2.78338607 |
| 61 | Hypothermia (HP:0002045) | 2.78205634 |
| 62 | Chronic otitis media (HP:0000389) | 2.78047754 |
| 63 | Central scotoma (HP:0000603) | 2.74560063 |
| 64 | Ketosis (HP:0001946) | 2.70069284 |
| 65 | Hypokalemia (HP:0002900) | 2.67658913 |
| 66 | Split foot (HP:0001839) | 2.66325937 |
| 67 | Abnormality of permanent molar morphology (HP:0011071) | 2.66250712 |
| 68 | Abnormality of the dental root (HP:0006486) | 2.66250712 |
| 69 | Taurodontia (HP:0000679) | 2.66250712 |
| 70 | Vitreoretinal degeneration (HP:0000655) | 2.64905082 |
| 71 | Overfolded helix (HP:0000396) | 2.63844295 |
| 72 | Hyperkalemia (HP:0002153) | 2.62100711 |
| 73 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.61917947 |
| 74 | Abnormality of the parietal bone (HP:0002696) | 2.61317932 |
| 75 | Abnormality of renin-angiotensin system (HP:0000847) | 2.57194853 |
| 76 | Abnormality of the lacrimal duct (HP:0011481) | 2.55474865 |
| 77 | Restlessness (HP:0000711) | 2.55019092 |
| 78 | Abnormality of potassium homeostasis (HP:0011042) | 2.53952676 |
| 79 | Hypophosphatemia (HP:0002148) | 2.52681845 |
| 80 | Abnormal pancreas size (HP:0012094) | 2.51565619 |
| 81 | Dyschromatopsia (HP:0007641) | 2.51193037 |
| 82 | Menstrual irregularities (HP:0000858) | 2.48304206 |
| 83 | Orthostatic hypotension (HP:0001278) | 2.46601132 |
| 84 | Abnormality of molar morphology (HP:0011070) | 2.45611548 |
| 85 | Abnormality of molar (HP:0011077) | 2.45611548 |
| 86 | Gonadal dysgenesis (HP:0000133) | 2.43519932 |
| 87 | Premature skin wrinkling (HP:0100678) | 2.42489694 |
| 88 | Partial duplication of thumb phalanx (HP:0009944) | 2.42364941 |
| 89 | Abnormality of dentin (HP:0010299) | 2.41571665 |
| 90 | Abnormality of macular pigmentation (HP:0008002) | 2.41214957 |
| 91 | Increased purine levels (HP:0004368) | 2.39655167 |
| 92 | Hyperuricemia (HP:0002149) | 2.39655167 |
| 93 | Abnormality of the metopic suture (HP:0005556) | 2.39590663 |
| 94 | Neuroendocrine neoplasm (HP:0100634) | 2.39515610 |
| 95 | Recurrent corneal erosions (HP:0000495) | 2.38051980 |
| 96 | Insulin resistance (HP:0000855) | 2.34769820 |
| 97 | Hepatoblastoma (HP:0002884) | 2.34548168 |
| 98 | Short clavicles (HP:0000894) | 2.33055258 |
| 99 | Vacuolated lymphocytes (HP:0001922) | 2.31383725 |
| 100 | Abnormality of the nasolacrimal system (HP:0000614) | 2.30754588 |
| 101 | Increased CSF protein (HP:0002922) | 2.29530892 |
| 102 | Coronal craniosynostosis (HP:0004440) | 2.29233515 |
| 103 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.27429040 |
| 104 | Hypoplasia of the fovea (HP:0007750) | 2.26222493 |
| 105 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.26222493 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 2.25920548 |
| 107 | Abnormally folded helix (HP:0008544) | 2.25484829 |
| 108 | Gonadotropin excess (HP:0000837) | 2.22879077 |
| 109 | Morphological abnormality of the middle ear (HP:0008609) | 2.22647101 |
| 110 | Aplasia of the phalanges of the hand (HP:0009802) | 2.20270610 |
| 111 | Aplasia involving bones of the extremities (HP:0009825) | 2.20270610 |
| 112 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.20270610 |
| 113 | Conjugated hyperbilirubinemia (HP:0002908) | 2.19216786 |
| 114 | Congenital glaucoma (HP:0001087) | 2.17236671 |
| 115 | Knee flexion contracture (HP:0006380) | 2.15781471 |
| 116 | Aplasia cutis congenita (HP:0001057) | 2.15531948 |
| 117 | Hypotension (HP:0002615) | 2.15487477 |
| 118 | Renal agenesis (HP:0000104) | 2.14890839 |
| 119 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.13983925 |
| 120 | Dysautonomia (HP:0002459) | 2.13712981 |
| 121 | Brushfield spots (HP:0001088) | 2.13477645 |
| 122 | Generalized hyperpigmentation (HP:0007440) | 2.13413356 |
| 123 | Median cleft lip (HP:0000161) | 2.12962310 |
| 124 | Atelectasis (HP:0100750) | 2.11914542 |
| 125 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 2.10181271 |
| 126 | Hypoplasia of the ulna (HP:0003022) | 2.09603548 |
| 127 | Hemiparesis (HP:0001269) | 2.07363759 |
| 128 | 2-3 toe syndactyly (HP:0004691) | 2.06119837 |
| 129 | Abdominal distention (HP:0003270) | 2.06060933 |
| 130 | Abnormality of the intrinsic pathway (HP:0010989) | 2.05678010 |
| 131 | Hypercortisolism (HP:0001578) | 2.05655786 |
| 132 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.04084460 |
| 133 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 2.04045152 |
| 134 | Hyperphosphaturia (HP:0003109) | 2.01412128 |
| 135 | Metaphyseal irregularity (HP:0003025) | 2.01228058 |
| 136 | Cortical visual impairment (HP:0100704) | 2.01222085 |
| 137 | Protuberant abdomen (HP:0001538) | 2.00981360 |
| 138 | Hyperpituitarism (HP:0010514) | 2.00574626 |
| 139 | Partial duplication of the phalanx of hand (HP:0009999) | 1.98735563 |
| 140 | Neurofibrillary tangles (HP:0002185) | 1.98314882 |
| 141 | Abnormality of male internal genitalia (HP:0000022) | 1.95657733 |
| 142 | Limb hypertonia (HP:0002509) | 1.94258581 |
| 143 | Tracheomalacia (HP:0002779) | 1.93543690 |
| 144 | Spontaneous abortion (HP:0005268) | 1.92641503 |
| 145 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.92429280 |
| 146 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.91127243 |
| 147 | Abnormality of the fovea (HP:0000493) | 1.90805965 |
| 148 | Hypocalcemia (HP:0002901) | 1.89937901 |
| 149 | Muscular hypotonia of the trunk (HP:0008936) | 1.86575326 |
| 150 | Abnormality of purine metabolism (HP:0004352) | 1.85951155 |
| 151 | Decreased central vision (HP:0007663) | 1.84122403 |
| 152 | Molar tooth sign on MRI (HP:0002419) | 1.83275895 |
| 153 | Abnormality of midbrain morphology (HP:0002418) | 1.83275895 |
| 154 | Hyperthyroidism (HP:0000836) | 1.83156826 |
| 155 | Neonatal short-limb short stature (HP:0008921) | 1.82997587 |
| 156 | Pheochromocytoma (HP:0002666) | 1.82301395 |
| 157 | Thoracolumbar scoliosis (HP:0002944) | 1.81442901 |
| 158 | Supernumerary ribs (HP:0005815) | 1.80200908 |
| 159 | Epiphyseal stippling (HP:0010655) | 1.79351612 |
| 160 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.78311759 |
| 161 | Abnormal urine phosphate concentration (HP:0012599) | 1.77851991 |
| 162 | Reticulocytopenia (HP:0001896) | 1.76797724 |
| 163 | Abnormality of the diencephalon (HP:0010662) | 1.76438175 |
| 164 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.74290947 |
| 165 | Abnormality of the dental pulp (HP:0006479) | 1.73578041 |
| 166 | Skin nodule (HP:0200036) | 1.73454623 |
| 167 | Abnormality of chloride homeostasis (HP:0011422) | 1.72684536 |
| 168 | Enlarged penis (HP:0000040) | 1.72647261 |
| 169 | Type II lissencephaly (HP:0007260) | 1.72503088 |
| 170 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.72372644 |
| 171 | Tinnitus (HP:0000360) | 1.70737271 |
| 172 | Abnormality of macrophages (HP:0004311) | 1.70308328 |
| 173 | Exocrine pancreatic insufficiency (HP:0001738) | 1.70259716 |
| 174 | Scotoma (HP:0000575) | 1.67788660 |
| 175 | Anxiety (HP:0000739) | 1.67009176 |
| 176 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.66654566 |
| 177 | Turricephaly (HP:0000262) | 1.66158428 |
| 178 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.65196897 |
| 179 | Focal segmental glomerulosclerosis (HP:0000097) | 1.64855514 |
| 180 | Limited elbow extension (HP:0001377) | 1.64333212 |
| 181 | Cerebral inclusion bodies (HP:0100314) | 1.63995940 |
| 182 | Visual hallucinations (HP:0002367) | 1.62301491 |
| 183 | Chronic bronchitis (HP:0004469) | 1.62197827 |
| 184 | Generalized hypopigmentation of hair (HP:0011358) | 1.61472528 |
| 185 | Tetany (HP:0001281) | 1.60831368 |
| 186 | Adrenal overactivity (HP:0002717) | 1.58709105 |
| 187 | Neoplasm of the heart (HP:0100544) | 1.57509759 |
| 188 | Progressive neurologic deterioration (HP:0002344) | 1.56879561 |
| 189 | White forelock (HP:0002211) | 1.56259831 |
| 190 | Gout (HP:0001997) | 1.56251118 |
| 191 | Upper limb muscle weakness (HP:0003484) | 1.54223680 |
| 192 | Duplicated collecting system (HP:0000081) | 1.54178180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 6.42468947 |
| 2 | TLK1 | 5.11982623 |
| 3 | INSRR | 4.79275473 |
| 4 | PIK3CG | 4.79108617 |
| 5 | TAOK3 | 4.73357906 |
| 6 | MAPK15 | 4.51004102 |
| 7 | FRK | 3.27694854 |
| 8 | MAP3K10 | 3.17363318 |
| 9 | PRKD3 | 3.01141091 |
| 10 | UHMK1 | 2.91593995 |
| 11 | WNK4 | 2.81277553 |
| 12 | EPHA3 | 2.51976160 |
| 13 | HIPK2 | 2.51801836 |
| 14 | STK16 | 2.02893872 |
| 15 | MATK | 2.01364046 |
| 16 | PASK | 1.98960269 |
| 17 | MAP3K2 | 1.91712150 |
| 18 | STK4 | 1.91248475 |
| 19 | MST4 | 1.77211595 |
| 20 | VRK1 | 1.76061858 |
| 21 | SCYL2 | 1.64774407 |
| 22 | EPHA2 | 1.50291235 |
| 23 | WNK1 | 1.38523827 |
| 24 | KDR | 1.37354352 |
| 25 | NEK1 | 1.35087908 |
| 26 | CASK | 1.27836398 |
| 27 | CAMKK2 | 1.24513982 |
| 28 | NTRK1 | 1.24324977 |
| 29 | PTK6 | 1.22176060 |
| 30 | SIK2 | 1.21762138 |
| 31 | IKBKE | 1.19722351 |
| 32 | FGFR4 | 1.15452402 |
| 33 | FER | 1.14270643 |
| 34 | EPHB1 | 1.12935111 |
| 35 | GRK1 | 1.11982884 |
| 36 | FLT3 | 1.11316253 |
| 37 | MAP2K6 | 1.10726166 |
| 38 | MAP3K1 | 1.10422530 |
| 39 | PAK3 | 1.07518422 |
| 40 | MAP3K6 | 1.07492967 |
| 41 | DDR2 | 1.05896921 |
| 42 | IRAK1 | 1.04767899 |
| 43 | PRKCH | 1.02603406 |
| 44 | RPS6KB2 | 1.02350097 |
| 45 | NTRK3 | 1.01285876 |
| 46 | MST1R | 1.01171046 |
| 47 | MAP3K7 | 1.00107771 |
| 48 | PDGFRA | 0.99917492 |
| 49 | PTK2 | 0.99079543 |
| 50 | CDC42BPA | 0.99034304 |
| 51 | TGFBR1 | 0.97773347 |
| 52 | MAP4K2 | 0.97689603 |
| 53 | PKN1 | 0.97589358 |
| 54 | RIPK1 | 0.97585091 |
| 55 | IRAK3 | 0.96981954 |
| 56 | LRRK2 | 0.93713020 |
| 57 | ZAK | 0.93581390 |
| 58 | TBK1 | 0.91495723 |
| 59 | ABL2 | 0.90647606 |
| 60 | MAP3K4 | 0.90579856 |
| 61 | BMX | 0.89764422 |
| 62 | FGFR3 | 0.86874893 |
| 63 | BMPR1B | 0.85233770 |
| 64 | PRKD2 | 0.82151503 |
| 65 | PRKCE | 0.75646948 |
| 66 | CLK1 | 0.74218840 |
| 67 | TYRO3 | 0.72871067 |
| 68 | CAMK1 | 0.71954066 |
| 69 | FES | 0.71258639 |
| 70 | CSF1R | 0.70401815 |
| 71 | MAP3K14 | 0.69897060 |
| 72 | PRKCD | 0.68614836 |
| 73 | MAPKAPK3 | 0.67413257 |
| 74 | JAK1 | 0.66858862 |
| 75 | NLK | 0.66507866 |
| 76 | IKBKB | 0.65510906 |
| 77 | MAP2K7 | 0.63885050 |
| 78 | BCKDK | 0.62426135 |
| 79 | DAPK2 | 0.62113421 |
| 80 | BCR | 0.60288114 |
| 81 | ALK | 0.60156172 |
| 82 | ERN1 | 0.58305659 |
| 83 | MARK2 | 0.56272492 |
| 84 | CDK3 | 0.54157132 |
| 85 | LATS1 | 0.51172863 |
| 86 | RET | 0.51091800 |
| 87 | VRK2 | 0.50997426 |
| 88 | MET | 0.49784877 |
| 89 | DYRK1B | 0.49477494 |
| 90 | SGK3 | 0.49464232 |
| 91 | OBSCN | 0.46234040 |
| 92 | NEK6 | 0.46093229 |
| 93 | PRKAA1 | 0.45571465 |
| 94 | SIK1 | 0.45534668 |
| 95 | PDGFRB | 0.44793778 |
| 96 | EIF2AK3 | 0.43997267 |
| 97 | PHKG1 | 0.43743316 |
| 98 | PHKG2 | 0.43743316 |
| 99 | PRKCA | 0.42919213 |
| 100 | RPS6KA5 | 0.42053308 |
| 101 | SGK494 | 0.41763269 |
| 102 | SGK223 | 0.41763269 |
| 103 | KIT | 0.41331126 |
| 104 | NTRK2 | 0.40876993 |
| 105 | MAP3K8 | 0.40059262 |
| 106 | DYRK3 | 0.39685010 |
| 107 | MAPK1 | 0.38047456 |
| 108 | PRKCI | 0.37666732 |
| 109 | ICK | 0.37027217 |
| 110 | NUAK1 | 0.37004924 |
| 111 | CSNK2A1 | 0.36267163 |
| 112 | INSR | 0.36182959 |
| 113 | CAMK2D | 0.35554288 |
| 114 | GSK3A | 0.34169104 |
| 115 | PRKG2 | 0.33601125 |
| 116 | PRKD1 | 0.31921240 |
| 117 | CHEK2 | 0.31822587 |
| 118 | PRKACB | 0.31177390 |
| 119 | DAPK3 | 0.31066764 |
| 120 | FGR | 0.31058193 |
| 121 | STK38L | 0.30517839 |
| 122 | AURKB | 0.29965033 |
| 123 | STK24 | 0.29475674 |
| 124 | TRIB3 | 0.28626261 |
| 125 | SIK3 | 0.27839515 |
| 126 | SGK1 | 0.27211377 |
| 127 | MAPKAPK2 | 0.27067469 |
| 128 | LYN | 0.26414246 |
| 129 | CHUK | 0.25885996 |
| 130 | DYRK2 | 0.25687143 |
| 131 | MAPK3 | 0.25660686 |
| 132 | CSK | 0.25617111 |
| 133 | PRKCQ | 0.25097701 |
| 134 | CAMK2B | 0.24993830 |
| 135 | MTOR | 0.24880614 |
| 136 | ERBB2 | 0.24675156 |
| 137 | PRKAA2 | 0.24617403 |
| 138 | JAK3 | 0.24228130 |
| 139 | PRKACA | 0.24064931 |
| 140 | KSR2 | 0.23968733 |
| 141 | TEC | 0.23734574 |
| 142 | PDPK1 | 0.23723629 |
| 143 | MAPK10 | 0.23720333 |
| 144 | JAK2 | 0.23496765 |
| 145 | IGF1R | 0.23495522 |
| 146 | CDK5 | 0.23298187 |
| 147 | CSNK1G2 | 0.23261103 |
| 148 | BRD4 | 0.23065364 |
| 149 | FGFR1 | 0.22500904 |
| 150 | RPS6KB1 | 0.22353625 |
| 151 | DYRK1A | 0.22314958 |
| 152 | ADRBK2 | 0.21799155 |
| 153 | SGK2 | 0.20838681 |
| 154 | FGFR2 | 0.20515452 |
| 155 | PDK1 | 0.19633707 |
| 156 | PRKG1 | 0.19457749 |
| 157 | CAMK2A | 0.19405918 |
| 158 | ADRBK1 | 0.19306321 |
| 159 | MAP2K1 | 0.19148595 |
| 160 | ITK | 0.19117457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 7.69068608 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.25016430 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 3.81628901 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.70813410 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.19148325 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.13761527 |
| 7 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 3.01712852 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.80020824 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.76110053 |
| 10 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.34894819 |
| 11 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.33886254 |
| 12 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.33289530 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.30189931 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27189192 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.24479483 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.12619909 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.06179579 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.94412354 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.83166796 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.80260718 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.79502286 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.72250411 |
| 23 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.65839061 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.65063336 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.59722068 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.53247533 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47838878 |
| 28 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.42911499 |
| 29 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.42870618 |
| 30 | Circadian entrainment_Homo sapiens_hsa04713 | 1.39096960 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.37814170 |
| 32 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.36937157 |
| 33 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.35845027 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.35385242 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.33832219 |
| 36 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.32625698 |
| 37 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.31552354 |
| 38 | Taste transduction_Homo sapiens_hsa04742 | 1.30972697 |
| 39 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.30225963 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.29301734 |
| 41 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.29186753 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.28656236 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.28364916 |
| 44 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.27274919 |
| 45 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.26044403 |
| 46 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.25314081 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23979372 |
| 48 | GABAergic synapse_Homo sapiens_hsa04727 | 1.23482799 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.21214905 |
| 50 | Morphine addiction_Homo sapiens_hsa05032 | 1.20794253 |
| 51 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.18237724 |
| 52 | Mineral absorption_Homo sapiens_hsa04978 | 1.17687245 |
| 53 | Phototransduction_Homo sapiens_hsa04744 | 1.17060809 |
| 54 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.16005393 |
| 55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.15996312 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15483638 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 1.12288709 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 1.12157560 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.09679495 |
| 60 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.09388780 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.08190404 |
| 62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.08062755 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.06314160 |
| 64 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.05849057 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 1.05282486 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04975517 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04060274 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00478790 |
| 69 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.99653037 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99575244 |
| 71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99445946 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.97280821 |
| 73 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.93953384 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93924626 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.93678738 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.93446922 |
| 77 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.93237035 |
| 78 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92713287 |
| 79 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91240080 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89882054 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.89127439 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87914084 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87515547 |
| 84 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.85786483 |
| 85 | Leishmaniasis_Homo sapiens_hsa05140 | 0.84526124 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.83517340 |
| 87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80681132 |
| 88 | Gap junction_Homo sapiens_hsa04540 | 0.79800782 |
| 89 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.79781968 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.79358822 |
| 91 | Long-term depression_Homo sapiens_hsa04730 | 0.79260100 |
| 92 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76236900 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75544877 |
| 94 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.74822954 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.72953686 |
| 96 | Asthma_Homo sapiens_hsa05310 | 0.72397551 |
| 97 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71893975 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.71571393 |
| 99 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70410459 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70175336 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69133087 |
| 102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68849907 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68374890 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68075017 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66986588 |
| 106 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66560402 |
| 107 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60617248 |
| 108 | Base excision repair_Homo sapiens_hsa03410 | 0.60183859 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60172577 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59242980 |
| 111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58585278 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58192968 |
| 113 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57015152 |
| 114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56224632 |
| 115 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56048303 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55940081 |
| 117 | Allograft rejection_Homo sapiens_hsa05330 | 0.55864157 |
| 118 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55381333 |
| 119 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54096295 |
| 120 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53775836 |
| 121 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.53306851 |
| 122 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52904544 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52164591 |
| 124 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50935025 |
| 125 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50146707 |
| 126 | Parkinsons disease_Homo sapiens_hsa05012 | 0.48985205 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48376853 |
| 128 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46720848 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45467286 |
| 130 | Salmonella infection_Homo sapiens_hsa05132 | 0.45445407 |
| 131 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45336742 |
| 132 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44049148 |
| 133 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43208096 |
| 134 | Malaria_Homo sapiens_hsa05144 | 0.42645617 |
| 135 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42274728 |
| 136 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42007206 |
| 137 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39050633 |
| 138 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.37556648 |
| 139 | Olfactory transduction_Homo sapiens_hsa04740 | 0.37408664 |
| 140 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36835905 |
| 141 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36565902 |
| 142 | Purine metabolism_Homo sapiens_hsa00230 | 0.35979950 |
| 143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35889396 |
| 144 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.35504252 |
| 145 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35200884 |
| 146 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34308151 |
| 147 | Amoebiasis_Homo sapiens_hsa05146 | 0.33490448 |
| 148 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.33174805 |
| 149 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31553102 |
| 150 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30183002 |
| 151 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.29540814 |
| 152 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29246559 |
| 153 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29187340 |
| 154 | Lysine degradation_Homo sapiens_hsa00310 | 0.28607152 |
| 155 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.28046807 |
| 156 | Nicotine addiction_Homo sapiens_hsa05033 | 0.27359538 |
| 157 | Bile secretion_Homo sapiens_hsa04976 | 0.27276194 |
| 158 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.27020814 |
| 159 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.26649372 |
| 160 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.25265820 |
| 161 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.23265944 |
| 162 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.23060365 |
| 163 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.22817395 |
| 164 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.22319399 |
| 165 | Platelet activation_Homo sapiens_hsa04611 | 0.22311461 |
| 166 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.21769146 |
| 167 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21767416 |
| 168 | Alcoholism_Homo sapiens_hsa05034 | 0.20328883 |

